FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to novel BICYCLE aromatic compounds of the general formula (I) showing capacity to bind RXRα and to a pharmaceutical composition based on thereof that can be used in medicine, veterinary science and cosmetics. Compounds correspond to the general formula (I) where R1 is CH3,CH2OR2,COR3; R2 and R3 have values indicated below; Ar1 means groups taken among (a) , (b) , (c) ; R4-R11 have values indicated below; Ar2 means radical ; X means radical taken among groups (i) , (j) , (l) ; R2 means hydrogen atom, lower alkyl or radical CO-R16; R3 means -OR17; R4 means hydrogen atom, -OR18; R5 means lower alkyl; R6 means tert.-butyl; R7 means +OR20, lower alkyl; R8 means tert.-butyl, adamantyl; R9 and R10 taken in common form with an adjacent aromatic ring a 6-membered ring optionally substituted with methyl groups; R11 means lower alkyl comprising from 1 to 9 carbon atoms, lower alkoxy-group, -OR21, polyester group. Other values of radicals have values indicated in the invention claim. A pharmaceutical composition comprises at least one compound among compounds of the general formula (I) and taken mainly in the amount from 0.001 to 5 wt.% of total composition. EFFECT: new compounds indicated above, valuable properties. 13 cl, 46 ex
Authors
Dates
2002-08-27—Published
1999-03-30—Filed